Health and Wellness
Segment on all things health and wellness from physical and mental
-
FDA Approves First Freeze-Dried Plasma, Mounjaro for Heart Risk, First Oral Dermatomyositis Drug
The FDA has cleared three notable healthcare developments: Ezplaz Freeze Dried Plasma, a new cardiovascular-risk indication for Mounjaro (tirzepatide), and…
Read More » -
Statins Linked to Lower Dementia Risk, FDA Approves First Daily Cholesterol Pill
New health news is connecting cholesterol care, brain health and medication access. A 15-year Danish registry study presented at ESC…
Read More » -
FDA Approves Updated COVID-19 Vaccines Targeting New Subvariant
The U.S. Food and Drug Administration has approved updated 2026–2027 COVID-19 vaccines from Moderna, Pfizer-BioNTech and Novavax-Sanofi. The new shots…
Read More » -
Shingles Vaccine Linked to Lower Risk of Heart Attack and Stroke, Study Finds
August 27, 2026 A study published in Nature Medicine found that adults age 60 and older who received the Shingrix…
Read More » -
FDA Approves First Wearable That Tracks Blood Sugar and Ketones Together
The FDA has authorized Abbott’s Libre Duo 10-Day Continuous Dual Glucose Ketone Monitoring System for people with diabetes ages 2…
Read More » -
US Measles Outbreak Accelerates With Cases Across 45 States
The U.S. measles outbreak is accelerating. The CDC added 211 new infections in its latest weekly update, bringing the 2026…
Read More » -
COVID Cases Climb in Summer Wave Across South and West, Health Officials Say
COVID-19 activity is climbing across the United States in a summer wave, with the South and West seeing some of…
Read More » -
mRNA Cancer Vaccine Shows ‘Landmark’ Results in Melanoma Trial
A personalized mRNA cancer vaccine from Moderna and Merck has shown promising results in a Phase 3 trial involving 1,137…
Read More » -
Wellness Watch: Today’s Health Developments You Should Know
As of August 18, the latest U.S. health updates point to a familiar message: everyday prevention still matters. CDC respiratory-virus…
Read More » -
FDA Approves First mRNA Flu Vaccine for Older Adults Amid Seasonal Readiness Concerns
The U.S. Food and Drug Administration has approved mFlusiva, Moderna’s first mRNA-based seasonal influenza vaccine, for adults 50 and older.…
Read More »